Denied
The Board found that the reduction in disability evaluation for the service-connected prostate adenocarcinoma with dysuria and voiding dysfunction, from 100 percent disabling to 20 percent disabling, effective July 1, 2021, was proper.
The deciding factor: The September 2020 examination demonstrated improvement in the Veteran's condition, specifically increased urinary frequency with daytime voiding interval between one and two hours, and nighttime awakening to void three to four times. This supported a reduction from 100 percent to 20 percent disabling.
- Claimed conditions
- prostate adenocarcinoma with dysuria and voiding dysfunction
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 20%
- Decision date
- January 31, 2025
- Citation
- A25009150
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.